Add-On to GLP-1s Yields Greater Weight Loss

Combination therapy of bupropion/naltrexone and GLP-1 receptor agonists showed a synergistic weight loss effect in individuals with obesity who responded poorly to GLP-1 monotherapy.

Related Keywords

Canada ,Vancouver ,British Columbia ,United Kingdom ,British ,James Naude ,International Journal Of Obesity ,University Of British Columbia ,International Journal ,